PYRIDINIUM DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
A series of carbamates based on the structure of pyridostigmine (PYR) were synthesized and evaluated as potential drugs for the treatment of cognitive impairments associated with cholinergic perturbance such as in Alzheimer's disease. These compounds were examined for their cholinesterase inhib...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ADANI, RACHEL AMITAI, GABRIEL HELDMAN, ELIAHU RACHAMAN, ELIEZER |
| description | A series of carbamates based on the structure of pyridostigmine (PYR) were synthesized and evaluated as potential drugs for the treatment of cognitive impairments associated with cholinergic perturbance such as in Alzheimer's disease. These compounds were examined for their cholinesterase inhibition, pharmacokinetics, acute toxicity, lipophilicity, reversal of scopolamine induced memory impairment in rats (passive avoidance) and analgesia in mice. These compounds include N-alkyl-PYR and various sugar-N-alkyl-PYR conjugates, being 3-position substituted pyridinium derivatives of general formula (I). Some of the new compounds are less toxic than PYR in rats and may serve for the treatment of other CNS-related diseases such as stroke and PNS-diseases such as: mysthenia gravis, glaucoma, neurogenic urinary bladder, neuralgic pains and as a pretreatment of organophosphorus intoxication. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0851859A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0851859A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0851859A13</originalsourceid><addsrcrecordid>eNrjZHALiAzydPH08wz1VXBxDfIMcwzxDHMNVnD0c1EI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGcvxCHIHa_NwVQjxcfXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgIGFqaGFqaWjoTERSgCe-SyC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIDINIUM DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM</title><source>esp@cenet</source><creator>ADANI, RACHEL ; AMITAI, GABRIEL ; HELDMAN, ELIAHU ; RACHAMAN, ELIEZER</creator><creatorcontrib>ADANI, RACHEL ; AMITAI, GABRIEL ; HELDMAN, ELIAHU ; RACHAMAN, ELIEZER</creatorcontrib><description>A series of carbamates based on the structure of pyridostigmine (PYR) were synthesized and evaluated as potential drugs for the treatment of cognitive impairments associated with cholinergic perturbance such as in Alzheimer's disease. These compounds were examined for their cholinesterase inhibition, pharmacokinetics, acute toxicity, lipophilicity, reversal of scopolamine induced memory impairment in rats (passive avoidance) and analgesia in mice. These compounds include N-alkyl-PYR and various sugar-N-alkyl-PYR conjugates, being 3-position substituted pyridinium derivatives of general formula (I). Some of the new compounds are less toxic than PYR in rats and may serve for the treatment of other CNS-related diseases such as stroke and PNS-diseases such as: mysthenia gravis, glaucoma, neurogenic urinary bladder, neuralgic pains and as a pretreatment of organophosphorus intoxication.</description><edition>6</edition><language>eng ; fre ; ger</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980708&DB=EPODOC&CC=EP&NR=0851859A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980708&DB=EPODOC&CC=EP&NR=0851859A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ADANI, RACHEL</creatorcontrib><creatorcontrib>AMITAI, GABRIEL</creatorcontrib><creatorcontrib>HELDMAN, ELIAHU</creatorcontrib><creatorcontrib>RACHAMAN, ELIEZER</creatorcontrib><title>PYRIDINIUM DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM</title><description>A series of carbamates based on the structure of pyridostigmine (PYR) were synthesized and evaluated as potential drugs for the treatment of cognitive impairments associated with cholinergic perturbance such as in Alzheimer's disease. These compounds were examined for their cholinesterase inhibition, pharmacokinetics, acute toxicity, lipophilicity, reversal of scopolamine induced memory impairment in rats (passive avoidance) and analgesia in mice. These compounds include N-alkyl-PYR and various sugar-N-alkyl-PYR conjugates, being 3-position substituted pyridinium derivatives of general formula (I). Some of the new compounds are less toxic than PYR in rats and may serve for the treatment of other CNS-related diseases such as stroke and PNS-diseases such as: mysthenia gravis, glaucoma, neurogenic urinary bladder, neuralgic pains and as a pretreatment of organophosphorus intoxication.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHALiAzydPH08wz1VXBxDfIMcwzxDHMNVnD0c1EI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGcvxCHIHa_NwVQjxcfXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgIGFqaGFqaWjoTERSgCe-SyC</recordid><startdate>19980708</startdate><enddate>19980708</enddate><creator>ADANI, RACHEL</creator><creator>AMITAI, GABRIEL</creator><creator>HELDMAN, ELIAHU</creator><creator>RACHAMAN, ELIEZER</creator><scope>EVB</scope></search><sort><creationdate>19980708</creationdate><title>PYRIDINIUM DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM</title><author>ADANI, RACHEL ; AMITAI, GABRIEL ; HELDMAN, ELIAHU ; RACHAMAN, ELIEZER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0851859A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>1998</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>ADANI, RACHEL</creatorcontrib><creatorcontrib>AMITAI, GABRIEL</creatorcontrib><creatorcontrib>HELDMAN, ELIAHU</creatorcontrib><creatorcontrib>RACHAMAN, ELIEZER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ADANI, RACHEL</au><au>AMITAI, GABRIEL</au><au>HELDMAN, ELIAHU</au><au>RACHAMAN, ELIEZER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIDINIUM DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM</title><date>1998-07-08</date><risdate>1998</risdate><abstract>A series of carbamates based on the structure of pyridostigmine (PYR) were synthesized and evaluated as potential drugs for the treatment of cognitive impairments associated with cholinergic perturbance such as in Alzheimer's disease. These compounds were examined for their cholinesterase inhibition, pharmacokinetics, acute toxicity, lipophilicity, reversal of scopolamine induced memory impairment in rats (passive avoidance) and analgesia in mice. These compounds include N-alkyl-PYR and various sugar-N-alkyl-PYR conjugates, being 3-position substituted pyridinium derivatives of general formula (I). Some of the new compounds are less toxic than PYR in rats and may serve for the treatment of other CNS-related diseases such as stroke and PNS-diseases such as: mysthenia gravis, glaucoma, neurogenic urinary bladder, neuralgic pains and as a pretreatment of organophosphorus intoxication.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP0851859A1 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | PYRIDINIUM DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A38%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ADANI,%20RACHEL&rft.date=1998-07-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0851859A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |